Brian G. M. Durie, MD
Dr. Brian Durie is an attending physician at the Cedars-Sinai Medical Center, with offices in the Samuel Oschin Cancer Center. Dr. Durie's clinical expertise is in multiple myeloma. He is the Senior Advisor for Hematologic Malignancies and National Program Director for Multiple Myeloma and Related Disorders for Aptium Oncology.
Previously, Dr. Durie was a professor at the University of Arizona College of Medicine and the Charing Cross and Westminster School of Medicine at the University of London. Dr. Durie is board certified by the American Board of Internal Medicine with subspecialties in both medical oncology and hematology.
Dr. Durie, along with Dr. Sydney Salmon, co-created the Durie/Salmon Staging System, which is used worldwide for evaluating patients with myeloma. He is the recipient of numerous honors and awards for excellence. Dr. Durie received the Leukemia Society of America Scholar award, and was also the U.S Hematologic Research Foundation Annual Awardee. In addition, Dr. Durie received the 2006 Robert A. Kyle Lifetime Achievement Award which honors a physician who most exemplifies singular dedication to and compassion for myeloma patients in the search for the best treatment for myeloma. Dr. Durie founded and now chairs the International Myeloma Foundation and serves on its Scientific Advisory Board. Dr. Durie is also a Marquis member of "Who's Who in America" and "The Best Doctors in America."
Dr. Durie has written over 400 research papers, sixteen book chapters and five books; he has published research manuscripts in both basic research journals as well as major clinical journals such as New England Journal of Medicine. Dr. Durie is also an international patent holder for scintillation autoradiography.
Dr. Durie completed his residencies and fellowships at the Mayo Clinic and the University of Minnesota. He received his medical degree from the University of Edinburgh Medical School, Scotland in 1966.